Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.

ABSTRACT:

SUBMITTER: Tepper SJ 

PROVIDER: S-EPMC7496706 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature